Skip to content

Comparing Efficacy of Postoperative Oral Antibiotic Use in Trans-Oral Thyroidectomy

Comparing Efficacy of Postoperative Antibiotic Use in Transoral Thyroidectomy: a Prospective Randomized Controlled Trial Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03295955
Acronym
POTO
Enrollment
50
Registered
2017-09-28
Start date
2017-09-04
Completion date
2018-12-03
Last updated
2017-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgical Wound Infection, Thyroid Nodule

Brief summary

Transoral endoscopic thyroid surgery is a emerging surgical technique for thyroid surgery. This study to investigate the need for postoperative antibiotics in transoral endoscopic thyroid surgery.

Detailed description

To prevent possible infection from the oral cavity flora, most surgeons prescribe postoperative oral antibiotics more than 3 to 7 days after surgery. Currently, there's no clinical evidence that postoperative oral antibiotics is necessary or not in transoral endoscopic thyroid surgery. The investigator will conduct randomization after transoral thyroid surgery with two groups : postoperative oral antibiotics group versus no oral antibiotics group.

Interventions

Per-oral Amoxicillin Clavulanate Given or Non-given, after surgery

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Patients who planned to Transoral endoscopic thyroidectomy * Age between 20 to 70 * Voluntarily consenting to the study and study agreement * No local invasion or distant metastasis * Normal vocal cord function in laryngoscopic exam * No significant abnormalities in preoperative laboratory tests

Exclusion criteria

* Take aspirin or antiplatelet drugs within 7 days before admission * Uncontrolled hypertension, diabetes, chronic renal failure, or coagulation disease * History of cardiovascular disease (angina pectoris, heart failure, myocardial infarction, history of coronary artery disease, stroke, transient ischemic attack) * Substance abuse and alcohol abuse * History of esophageal and airway diseases * Patient was participated in other clinical trials within 30 days * History of neck irradiation or surgery * History of drug allergies * Pregnant or lactating women

Design outcomes

Primary

MeasureTime frameDescription
CDC 1992 SSI table scorePostoperative 1 dayClinical evidence of Surgical Site Infection
CBC, CRPPostoperative 1 dayLaboratory test

Secondary

MeasureTime frameDescription
Change of CDC 1992 SSI table scoreCompare the CDC 1992 SSI table score between postoperative 1 day and 2 day/2 weeks.Clinical evidence of Surgical Site Infection
Change of CBC, CRPCompare the CBC, CRP between postoperative 1 day and 2 dayLaboratory test

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026